Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Source Code Capital is a leading Beijing-based venture capital firm founded in 2014. It invests across multiple sectors including information technology, biotechnology, healthcare, artificial intelligence, intelligent manufacturing, and green development. The firm manages over $5 billion in assets and has invested in more than 300 companies at various stages from seed to growth. Notable investments include ByteDance and Meituan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Source Code Capital.